{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:00:34Z","timestamp":1792429234075,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.amjcard.2026.02.042","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:03:02Z","timestamp":1772092982000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The Long-Term Clinical Progression of Genotype-Positive\/Phenotype-Negative Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-7218","authenticated-orcid":false,"given":"Veronika","family":"Puchnerova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jensovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Zoubkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Peldova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Votypka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Macek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Ostadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.02.042_bib0001","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12265-016-9681-5","article-title":"Evaluation of the Mayo clinic phenotype-based genotype predictor score in patients with clinically diagnosed hypertrophic cardiomyopathy","volume":"9","author":"Murphy","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0003","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5114\/aoms.2018.78767","article-title":"The utility of the Mayo score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy","volume":"15","author":"Bonaventura","year":"2019","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0004","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","article-title":"Yield of genetic testing in hypertrophic cardiomyopathy","volume":"80","author":"Van","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mayocp.2014.01.025","article-title":"Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy","volume":"89","author":"Bos","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033565","article-title":"Relationship between genotype status and clinical outcome in hypertrophic cardiomyopathy","volume":"13","author":"Bonaventura","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11886-000-0010-9","article-title":"Molecular genetics of hypertrophic cardiomyopathy","volume":"2","author":"Towbin","year":"2000","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0008","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.83.6.580","article-title":"Familial hypertrophic cardiomyopathy","volume":"83","author":"Bonne","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028974","article-title":"Is hypertrophic cardiomyopathy always a familial and inherited disease?","volume":"12","author":"Bonaventura","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0011","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0012","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0013","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0014","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","article-title":"Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy","volume":"152","author":"Gray","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0017","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.111.090514","article-title":"Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing","volume":"127","author":"Jensen","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0019","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacc.2024.12.010","article-title":"Genes associated with hypertrophic cardiomyopathy: a reappraisal by the ClinGen hereditary cardiovascular disease gene curation Expert panel","volume":"85","author":"Hespe","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s Inherited Cardiomyopathy Expert Panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132951","article-title":"Family screening for hypertrophic cardiomyopathy: initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals","volume":"422","author":"Schoonvelde","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0022","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/eurheartj\/ehp306","article-title":"Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers","volume":"30","author":"Michels","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0023","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2024.08.011","article-title":"Family screening in hypertrophic cardiomyopathy: identification of relatives with low yield from systematic follow-up","volume":"84","author":"Silajdzija","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0024","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0026","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/hrt.63.5.308","article-title":"Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass","volume":"63","author":"Maron","year":"1990","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0027","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.hrthm.2009.04.029","article-title":"Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy","volume":"6","author":"Christiaans","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008123","article-title":"Long-term outcome in high-risk patients with hypertrophic cardiomyopathy after primary prevention defibrillator implants","volume":"13","author":"Rowin","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020227","article-title":"Myocardial perfusion defects in hypertrophic cardiomyopathy mutation carriers","volume":"10","author":"Hughes","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0030","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2006.08.036","article-title":"Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac Magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations","volume":"48","author":"Germans","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1532-429X-10-58","article-title":"Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype","volume":"10","author":"Strijack","year":"2008","journal-title":"J Cardiovasc Magnet Reson"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcmg.2011.08.020","article-title":"CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy","volume":"5","author":"Rowin","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0034","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0035","first-page":"1392","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0037","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamacardio.2025.4466","article-title":"Physical activity and cardiovascular outcomes in phenotype-negative cardiomyopathy variant carriers","volume":"11","author":"Ajufo","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0039","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.02.042_bib0040","first-page":"783","article-title":"ACCF\/AHA Guideline 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:00:05Z","timestamp":1777431605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S0002914926000974"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.042","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Long-Term Clinical Progression of Genotype-Positive\/Phenotype-Negative Patients With Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}